pseudomonas aeruginosa | porphyromonas gingivalis | helicobacter pylori kx2 mgep | aeromonas cavia | aggregatibacter actinomycetemcomitans | GeneSet Name |
-0.01432 | -0.02524 | -0.06290 | -0.00804 | -0.00227 | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP |
-0.01606 | -0.00011 | -0.11988 | -0.14365 | -0.00106 | NCI_CDC20_PHOSPHO_APC_C_MEDIATED_DEGRADATION_OF_CYCLIN_A |
-0.02932 | -0.00049 | -0.18250 | -0.12840 | -0.00670 | NCI_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C |
-0.00096 | -0.00002 | -0.13703 | -0.01738 | -0.01005 | REACTOME_CELL_CYCLE_MITOTIC |
-0.00892 | -0.00004 | -0.07915 | -0.13836 | -0.00052 | REACTOME_REGULATION_OF_APC_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE |
-0.12022 | -0.03945 | -0.18499 | -0.00075 | -0.00022 | YU_MYC_TARGETS_UP |
-0.18953 | -0.19892 | -0.08392 | -0.00002 | -0.00007 | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP |
-0.01770 | -0.00008 | -0.15231 | -0.18920 | -0.00108 | REACTOME_CDC20_PHOSPHO_APC_MEDIATED_DEGRADATION_OF_CYCLIN_A |
-0.00118 | -0.04603 | -0.13075 | -0.10708 | -0.00156 | CROONQUIST_NRAS_SIGNALING_DN |
-0.02924 | -0.00835 | -0.05496 | -0.08510 | -0.00010 | RHODES_UNDIFFERENTIATED_CANCER |
-0.01131 | -0.14187 | -0.19829 | -0.01561 | -0.00933 | ALONSO_METASTASIS_UP |
-0.00006 | -0.00284 | -0.11953 | -0.00408 | -0.00039 | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN |
-0.00995 | -0.02965 | -0.04704 | -0.13798 | -0.00008 | LEE_EARLY_T_LYMPHOCYTE_UP |
-0.00092 | -0.00394 | -0.01474 | -0.00510 | -0.00051 | PAL_PRMT5_TARGETS_UP |
-0.03272 | -0.00054 | -0.07941 | -0.02538 | -0.00045 | CROONQUIST_IL6_DEPRIVATION_DN |
-0.07989 | -0.02597 | -0.05716 | -0.01113 | -0.00118 | MORI_IMMATURE_B_LYMPHOCYTE_DN |
-0.09189 | -0.02032 | -0.07147 | -0.10956 | -0.00563 | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN |
-0.15890 | -0.00001 | -0.00628 | -0.00014 | -0.01265 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 |
-0.00283 | -0.10560 | -0.07914 | -0.07638 | -0.00046 | ZHAN_MULTIPLE_MYELOMA_PR_UP |
-0.04469 | -0.00196 | -0.01552 | -0.00031 | -0.01663 | KEGG_PARKINSONS_DISEASE |
-0.02813 | -0.03260 | -0.00633 | -0.08123 | -0.04933 | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP |
-0.01466 | -0.05467 | -0.15550 | -0.05430 | -0.03439 | SANA_RESPONSE_TO_IFNG_DN |
-0.01279 | -0.00366 | -0.06916 | -0.00040 | -0.07824 | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
-0.13346 | -0.18750 | -0.02846 | -0.17645 | -0.01043 | NUYTTEN_NIPP1_TARGETS_DN |
-0.00284 | -0.12425 | -0.06341 | -0.00011 | -0.00031 | LEE_LIVER_CANCER_SURVIVAL_DN |
-0.00115 | -0.00360 | -0.08461 | -0.09241 | -0.12376 | NUYTTEN_EZH2_TARGETS_DN |
-0.02054 | -0.00022 | -0.13553 | -0.15341 | -0.00303 | NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_SECURIN |
-0.07862 | -0.00024 | -0.19639 | -0.01895 | -0.04867 | MUELLER_PLURINET |
-0.08917 | -0.15592 | -0.17066 | -0.03439 | -0.00587 | MARKEY_RB1_ACUTE_LOF_DN |
-0.00107 | -0.01336 | -0.01179 | -0.01909 | -0.00008 | BLUM_RESPONSE_TO_SALIRASIB_DN |
-0.03095 | -0.00041 | -0.17213 | -0.13447 | -0.00827 | NCI_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 |
-0.00017 | -0.02164 | -0.17038 | -0.01238 | -0.00048 | BENPORATH_PROLIFERATION |